Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pfizer luxembourg sarl - metilprednizolon - prašek in vehikel za raztopino za injiciranje/infundiranje - metilprednizolon 59,7 mg / 1 ml - metilprednizolon

Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

le vet b.v. - prednizolon - kortikosteroidi za sistemsko zdravljenje, navaden, prednizolon, sistemsko hormonski preparati, razen. spolni hormoni in insulina - konji - zmanjševanje vnetnih in kliničnih parametrov, povezanih s ponavljajočo se obstrukcijo dihalnih poti (rao) pri konjih, v kombinaciji z nadzorom okolja.

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dechra regulatory -

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kemofarmacija d.d. - tableta - prednizolon

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kemofarmacija d.d. - tableta - prednizolon

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

medicopharmacia, d.o.o. - tableta - prednizolon

Slovėnija - slovėnų - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

veyx -

Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - antineoplastična sredstva - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.

Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.